» Articles » PMID: 35967162

The Role of Leptin in Systemic Lupus Erythematosus: Is It Still a Mystery?

Abstract

Systemic lupus erythematosus (SLE) is a chronic inflammatory connective tissue disease with varying clinical manifestations. Recent studies have proposed that leptin may be related to SLE development. This study aims to assess current information regarding the relationship between leptin and SLE. A systematic search was done using PubMed, Google Scholar, ScienceDirect, Epistemonikos, and Cochrane Library databases. Studies published in the English language in the last 10 years were selected based on predefined eligibility criteria. The quality of the studies was evaluated using the Newcastle-Ottawa Scale and the Assessment of Multiple Systematic Reviews 2 tool. A total of 12 studies were included in this systematic review. These included systematic reviews/meta-analyses, cross-sectional studies, and case-control studies Based on the findings of this review, we conclude thatleptin is significantly elevated in SLE patients; however, it does not seem to correlate with disease activity. The exact mechanism of leptin in the pathogenesis of the disease remains unknown and further research is needed regarding this aspect.

Citing Articles

Hyperleptinemia as a Marker of Various Phenotypes of Obesity and Overweight in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus.

Kondratyeva L, Gorbunova Y, Panafidina T, Popkova T Dokl Biochem Biophys. 2024; 517(1):182-194.

PMID: 38861143 DOI: 10.1134/S1607672924700893.


Mendelian randomization analyses reveal no genetic causal effects of major adipokines on systemic lupus erythematosus.

Duan P, Tian S PLoS One. 2024; 19(5):e0301699.

PMID: 38805491 PMC: 11132459. DOI: 10.1371/journal.pone.0301699.


Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome.

Corona-Meraz F, Vazquez-Del Mercado M, Sandoval-Garcia F, Robles-De Anda J, Tovar-Cuevas A, Rosales-Gomez R J Clin Med. 2024; 13(7).

PMID: 38610754 PMC: 11012563. DOI: 10.3390/jcm13071988.

References
1.
Yee C, Farewell V, Isenberg D, Griffiths B, Teh L, Bruce I . The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients. Rheumatology (Oxford). 2011; 50(5):982-8. PMC: 3077910. DOI: 10.1093/rheumatology/keq376. View

2.
Pan L, Lu M, Wang J, Xu M, Yang S . Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2019; 16(1):19-30. PMC: 7040062. DOI: 10.1007/s12519-019-00229-3. View

3.
Paul R, Hassan M, Nazar H, Gillani S, Afzal N, Qayyum I . Effect of body mass index on serum leptin levels. J Ayub Med Coll Abbottabad. 2013; 23(3):40-3. View

4.
do Carmo Martins M, Faleiro L, Fonseca A . [Relationship between leptin and body mass and metabolic syndrome in an adult population]. Rev Port Cardiol. 2012; 31(11):711-9. DOI: 10.1016/j.repc.2012.08.002. View

5.
Francisco V, Pino J, Campos-Cabaleiro V, Ruiz-Fernandez C, Mera A, Gonzalez-Gay M . Obesity, Fat Mass and Immune System: Role for Leptin. Front Physiol. 2018; 9:640. PMC: 5992476. DOI: 10.3389/fphys.2018.00640. View